Lepu Biopharma Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004SM4
HKD
5.46
0.33 (6.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
249.01
18.11
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
249.01
18.11
0.00
0.00
0.00
Raw Material Cost
144.59
113.32
114.79
94.52
55.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
219.79
219.02
308.79
91.70
209.69
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.70
10.06
6.85
97.00
59.60
Selling and Distribution Expenses
127.91
97.27
151.79
68.19
202.05
Other Expenses
17.10
29.61
55.97
15.35
-4.96
Total Expenditure (Excl Depreciation)
681.01
735.72
1,141.87
504.91
477.64
Operating Profit (PBDIT) excl Other Income
-432
-717.6
-1141.9
-504.90000000000003
-477.59999999999997
Other Income
253.08
64.76
59.36
13.80
5.99
Operating Profit (PBDIT)
-65.58
-541.86
-967.40
-396.60
-415.78
Interest
17.70
10.06
6.85
97.00
59.60
Exceptional Items
193.35
-112.97
-129.63
-87.64
-43.44
Gross Profit (PBDT)
104.43
-95.22
-114.79
-94.52
-55.86
Depreciation
113.34
110.99
114.79
94.52
55.86
Profit Before Tax
-3.27
-775.88
-1,218.68
-675.75
-574.69
Tax
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-24.42
-801.28
-1,218.46
-653.82
-506.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
-24.42
-801.28
-1,218.46
-653.82
-506.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
-9.07
-12.08
-21.54
-35.51
-77.62
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-33.48
-813.36
-1,240.00
-689.33
-584.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
1.1
1.12
1.22
1.19
1.12
Reserves
987.50
1,011.32
1,023.52
1,747.05
-394.30
Earnings per share (EPS)
-0.01
-0.48
-0.73
-0.39
-0.31
Diluted Earnings per share
-0.01
-0.48
-0.73
-0.39
-0.31
Operating Profit Margin (Excl OI)
-173.48%
-3962.9%
0.0%
0.0%
0.0%
Gross Profit Margin
44.2%
-3671.74%
0.0%
0.0%
0.0%
PAT Margin
-9.81%
-4424.94%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is 1,275.69% vs 0.00% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is 95.88% vs 34.40% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 47.46% vs 40.92% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 75.25% vs 48.53% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has improved from Dec 2022

Compare Annual Results Of Lepu Biopharma Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
249.01
3,486.95
-3,237.94
-92.86%
Other Operating Income
0.00
0.00
0.00
Total Operating income
249.01
3,486.95
-3,237.94
-92.86%
Raw Material Cost
144.59
883.35
-738.76
-83.63%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
219.79
0.00
219.79
Power Cost
0
0
0.00
Manufacturing Expenses
17.70
64.30
-46.60
-72.47%
Selling and Distribution Expenses
127.91
1,071.96
-944.05
-88.07%
Other Expenses
17.10
12.43
4.67
37.57%
Total Expenditure (Excl Depreciation)
681.01
2,143.91
-1,462.90
-68.24%
Operating Profit (PBDIT) excl Other Income
-432.00
1,343.03
-1,775.03
-132.17%
Other Income
253.08
66.49
186.59
280.63%
Operating Profit (PBDIT)
-65.58
1,409.52
-1,475.10
-104.65%
Interest
17.70
64.30
-46.60
-72.47%
Exceptional Items
193.35
0.00
193.35
Gross Profit (PBDT)
104.43
2,603.60
-2,499.17
-95.99%
Depreciation
113.34
0.00
113.34
Profit Before Tax
-3.27
1,345.22
-1,348.49
-100.24%
Tax
0.00
105.52
-105.52
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-24.42
1,239.70
-1,264.12
-101.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-24.42
1,239.70
-1,264.12
-101.97%
Share in Profit of Associates
0
0
0.00
Minority Interest
-9.07
0.00
-9.07
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-33.48
1,239.70
-1,273.18
-102.70%
Equity Capital
0
0
0.00
Face Value
1.10
0.00
0.00
Reserves
987.50
3,594.86
-2,607.36
-72.53%
Earnings per share (EPS)
-0.01
1.91
-1.92
-100.52%
Diluted Earnings per share
-0.01
1.91
-1.92
-100.52%
Operating Profit Margin (Excl OI)
-173.48%
38.52%
0.00
-212.00%
Gross Profit Margin
44.20%
38.58%
0.00
5.62%
PAT Margin
-9.81%
35.55%
0.00
-45.36%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 24.90 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 1,275.69% vs 0.00% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit -3.35 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 95.88% vs 34.40% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -31.87 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 47.46% vs 40.92% in Dec 2022

Annual - Interest
Interest 1.77 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 75.25% vs 48.53% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -173.48%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has improved from Dec 2022